VA-LINEAGE-LOGISTICS
27.10.2021 15:02:16 CEST | Business Wire | Press release
Lineage Logistics, LLC (“Lineage” or the “Company”), the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced the opening of its newest fully automated facility strategically located near the Port of Virginia’s world-renowned Virginia International Gateway in Portsmouth which offers an integrated network of highways, air, rail, and sea services.
The new state-of-the-art cold storage warehouse joins Lineage’s growing network of over 22 fully automated facilities worldwide. The Company’s growing automation presence comes at a critical time for the cold chain sector as the pandemic accelerated much-needed change to operations and systems within the decades-old cold storage industry. Lineage’s industry-leading automation technology increases storage density, maximizes capacity, provides real-time inventory management, and keeps food safe all while reducing energy consumption.
“As a testament to the power of public-private partnership, we are so pleased to announce the opening of our state-of-the-art facility in Portsmouth,” said Brian Beattie, Senior Vice President of Sale at Lineage Logistics. “Lineage’s innovative technology used in the Portsmouth warehouse will help our customers address rising supply chain demands both nationally and internationally while contributing to the ongoing economic development and job development in the region.”
Portsmouth Economic Development alongside the Virginia Economic Development Partnership, the Portsmouth Ports & Industrial Commission, and the Virginia Port Authority worked to secure the project for Lineage, which in the end resulted in the $84 million investment, produced over 80 high-paying jobs with a Portsmouth-first plan, and remediated a former chemical plant site that was previously vacant – all of which have benefited and will continue to support the city’s economic expansion.
“Portsmouth is thrilled to welcome Lineage Logistics to our business community,” said Shannon E. Glover, Mayor of Portsmouth. “Lineage has already become a wonderful community partner with its participation in our Portsmouth@Work programs, its commitment to supporting Portsmouth residents and businesses, and in the redevelopment of a key brownfield site. We look forward to Lineage continuing to grow in Portsmouth.”
The 167,264 square-foot facility, which is adjacent to the Virginia International Gateway, provides Lineage with access to key markets and will serve as a critical hub to connect people with food around the world. The facility will also aid in strengthening the supply chain and logistics infrastructure in Portsmouth as well as address the growing demand for cold storage in the region. The facility includes 26,000 pallet positions and blast freezing capabilities.
“This new cold storage facility is an important regional asset that is going to create jobs, provide greater flexibility to movers of cold cargo and help increase volumes of cold cargo moving across The Port of Virginia,” said Stephen A. Edwards, CEO and Executive Director of the Virginia Port Authority. “When we expanded and optimized Virginia International Gateway [just two years ago] we added a significant amount of capacity to handle cold cargo. Lineage’s new facility, which isn’t far from the gates at VIG, is going to help directly support our investment and make the port a destination for movers of cold cargo. We look forward to working with Lineage Logistics and helping to maximize its investment here.”
At 10:30 AM EST today, leaders from Lineage Logistics will be joined by Portsmouth community leaders and business partners, including Senator Louise Lucas, Secretary Brian Ball and Portsmouth Mayor Shannon Glover, to celebrate the hard work of the teams who transformed the facility from concept to reality. The event will include a ribbon-cutting ceremony, followed by group tours of the facility.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity which spans 15 countries across North America, Europe and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network, and development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was listed as No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005235/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock20.4.2026 01:07:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company’s common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling any shares of its common stock in the offering. The Selling Stockholder will receive all of the proceeds from the offering. Maxim Group LLC is acting as the sole book-running manager and Roth Capital Partners is acting as the co-manager for the offering. The offering is being made pursuant to the Com
Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms20.4.2026 01:01:00 CEST | Press release
Horse Powertrain, a global leader in innovative and low-emission powertrain systems, will unveil a new ‘all-in-one’ powertrain at Beijing Auto Show 2026: the X-Range C15 Direct Drive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260419640202/en/ Left-facing view of the HORSE X-Range C15 Direct Drive The ultra-compact X-Range C15 Direct Drive integrates a full hybrid powertrain – including a 4-cylinder engine, transmission, power electronics, and an electric motor – into a single compact unit with a shared housing, designed to mount to the rear subframe enabling a double isolated installation for best NVH. The X-Range C15 Direct Drive is designed as an ‘all-in-one’ powertrain to replace the rear electric drive unit of an existing BEV platform. It enables an automaker to use a single shared platform for their BEV, HEV, PHEV, and REEV lineups without any significant changes to vehicle design or production environments. The ne
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press release
CEO of Zhong, one of YouTube’s most-watched creators with 70 million subscribers and 95 million followers on all platforms, joins program The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press release
A pioneer in smoke-free tobacco products, Philip Morris International is the only company that has received modified risk tobacco product authorizations for heated tobacco products.In their order, FDA concluded that: “Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals” The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom